Novo Nordisk + OpenAI: How AI Is Designing the Next Generation of Diabetes Drugs
Novo Nordisk and OpenAI have partnered to use AI in drug discovery — and it could cut the time to find the next breakthrough diabetes treatment from 12 years to under 3.
Read article